Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation Meeting Abstract
| Authors: | Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A. |
| Abstract Title: | Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation |
| Meeting Title: | 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 51 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Apr 3-6 |
| Meeting Location: | Valencia, Spain |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2016-03-01 |
| Start Page: | S167 |
| Language: | English |
| ACCESSION: | WOS:000373357600289 |
| PROVIDER: | wos |
| PUBMED: | 26999538 |
| DOI: | 10.1038/bmt.2016.48 |
| Notes: | Meeting Abstract: P108-- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
